PURPLE BIOTECH LTD.
PPBTDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jan 1, 2027
18wMarket Overview
Stock performance and key metrics
1 upcoming, 1 past
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
NT219 | Phase 2 | Head and Neck Cancer | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in PURPLE BIOTECH LTD.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in PURPLE BIOTECH LTD.'s (PPBT) pipeline across Phase 2. Its lead program is NT219 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is PURPLE BIOTECH LTD.'s next FDA catalyst?→
PURPLE BIOTECH LTD.'s (PPBT) next tracked catalyst is a Phase 1 expected January 1, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track PPBT biotech catalysts?→
Add PPBT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PURPLE BIOTECH LTD.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.